QGEN Qiagen: Pangali Forward P/E

Simbol resmi perusahaan qiagen.com (QGEN)

Qiagen N.V. (QGEN) is implementing ESG principles by reducing plastic use and its carbon footprint within molecular diagnostics. This trend in the company's forward P/E ratio on the GURU.Markets chart confirms this, with the metric currently at 19.10. The business relies on stable laboratory demand with a sales peak in December, while R&D centers develop innovative DNA sequencing and purification systems.

Rasio rega marang bathi mangsa ngarep: Qiagen NV (QGEN) kanggo 04.07.2022 - 16.11.2026

Qiagen (QGEN) - rincian metrik lan laporan keuangan

- kuotasi lan prakiraan analis:
- data kapitalisasi saham perusahaan:
Analisis dhasar perusahaan:Qiagen Group QGEN
Produk mawa merek qiagen.com

The investment attractiveness of Qiagen N.V. (QGEN) is based on stable demand within the molecular diagnostics sector. The forward P/E compares the market value of the business with expected annual earnings, revealing valuation deviations from the fundamental trend. By analyzing the business's forward P/E, an investor can see capitalization efficiency driven by a reliable cash flow from consumables. This metric allows for the timely identification of whether the asset is overbought or undervalued.

Perusahaan pesaing

Prakiraan rega marang bathi TEM (Tempus AI, Inc)|Kapitalisasi marang proyeksi bathi Isis Pharmaceuticals|Pangali Forward P/E RGEN (repligen.com)|Rasio kapitalisasi marang bathi mangsa ngarep RNA (Avidity Biosciences, Inc.)|CRSP - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi WGS (GeneDx)|RARE: Pangali Forward P/E|Beam Therapeutics Corp - Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi SRPT|twistbioscience.com (TWST) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E TXG|NTLA (Intellia) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Stoke STOK|BioLife (BLFS) - Rasio prakiraan rega marang bathi|wavelifesciences.com - Pangali Forward P/E|Rasio rega marang bathi sing dikarepake MAZE|SION: Pangali Forward P/E|PRME - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi TSHA|QURE - Pangali forward rega marang bathi|Pangali Forward P/E MGTX|Kapitalisasi marang proyeksi bathi regenxbio.com|Pangali Forward P/E SLDB (Solid Biosciences Inc)|OCGN: Rasio rega marang bathi mangsa ngarep|PACB - Rega marang bathi mangsa ngarep|Benitec (BNTC) - Prakiraan rega marang bathi|DSGN: Pangali Forward P/E|RCKT: Rasio kapitalisasi marang bathi mangsa ngarep|FDMT (4D Molecular Therapeutics, Inc.) - Pangali Forward P/E|lexeotx.com (LXEO) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E KRRO|Prakiraan rega marang bathi Editas Medicine, Inc. EDIT|Rega marang bathi mangsa ngarep silence-therapeutics.com SLN|PRQR: Rasio rega marang bathi mangsa ngarep|CDXS - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Sangamo Therapeutics, Inc. SGMO|NAUT (nautilus.bio) - Prakiraan rega marang bathi|Rasio prakiraan rega marang bathi Metagenomi, Inc. (MGX)|Prakiraan rega marang bathi DTIL|Rasio rega marang bathi mangsa ngarep GBIO (generationbio.com)|Rega marang bathi mangsa ngarep Boundless Bio, Inc (BOLD)|Pangali Forward P/E Exicure Inc. (XCUR)|Imunon, Inc. - Prakiraan rega marang bathi|PHIO: Rasio rega marang bathi mangsa ngarep|MBIO - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake RNAZ|Bionano Genomics, Inc. (BNGO) - Rega marang bathi mangsa ngarep|Applied DNA Sciences, Inc. (APDN) - Pangali Forward P/E|BLUE (bluebirdbio.com) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep IPA (ImmunoPrecise Antibodies)|Pangali Forward P/E OMGA|Prakiraan rega marang bathi Singular Genomics Systems OMIC|Pangali Forward P/E RGLS (regulusrx.com)|Syros Pharmaceuticals Inc. (SYRS) - Rasio prakiraan rega marang bathi|TBIO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TCON (TRACON)|UBX: Pangali Forward P/E